Avidity Biosciences, Inc. (RNA)

Latest Insider Confidence Score

2026Q1

43.8
Bearish

Company insider confidence (by quarter)

2020Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Wong Roderick MP and CIO 3,995,000 Aug 6, 2021
Rtw Investments, Lp 10% Owner 3,995,000 Aug 6, 2021
Chen Bihua Director 2,214,545 Jun 18, 2020
Cormorant Asset Management, LP Other 2,214,545 Jun 18, 2020
Cormorant Global Healthcare Master Fund, LP 10% Owner 2,214,545 Jun 18, 2020

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Feb 27, 2026 McCarthy Teresa Chief Human Resources Officer Neutral 27.5 -165,296 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Thompson Tamar Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 MacLean Michael F CFO Neutral 27.5 -133,977 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Skerjanec Simona Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Hughes Steven George Chief Medical Officer Neutral 27.5 -115,857 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Boyce Sarah CEO Neutral 27.5 -474,861 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Moriarty John B Chief Legal Officer Neutral 27.5 -92,054 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Flanagan W. Michael Chief Scientific Officer Neutral 27.5 -150,365 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 WILSON TROY EDWARD Director Neutral 27.5 -78,802 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Gallagher Kathleen P. Chief Program Officer Neutral 27.5 -80,303 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Henig Noreen Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Kim Jean Jinsun Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 LEVIN ARTHUR A Director Neutral 27.5 -147,934 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Kaye Edward M. MD Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 BOESS CARSTEN Director Neutral 27.5 -6,692 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Mosbrooker Eric Chief Commercial Officer Neutral 27.5 -79,413 -100.00% ✗ -
Feb 27, 2026 Feb 27, 2026 Calderaro Charles III Chief Technical Officer Neutral 27.5 -98,547 -100.00% ✗ -
Jan 21, 2026 Jan 23, 2026 Hughes Steven George Chief Medical Officer Sell 25.0 -4,895 -13.41% ✓ $354.6K
Jan 21, 2026 Jan 23, 2026 Boyce Sarah CEO Sell 31.3 -14,387 -5.08% ✓ $1M
Jan 21, 2026 Jan 23, 2026 Flanagan W. Michael Chief Scientific Officer Sell 32.5 -6,534 -7.13% ✓ $473.4K
Jan 21, 2026 Jan 23, 2026 MacLean Michael F CFO Sell 32.5 -4,542 -7.12% ✓ $329.1K
Jan 21, 2026 Jan 23, 2026 LEVIN ARTHUR A Director Sell 46.3 -1,758 -1.02% ✓ $127.4K
Jan 21, 2026 Jan 23, 2026 McCarthy Teresa Chief Human Resources Officer Sell 42.5 -2,929 -2.51% ✓ $212.2K
Jan 7, 2026 Jan 9, 2026 Boyce Sarah CEO Sell 41.3 -8,576 -2.94% ✓ $619.4K
Jan 7, 2026 Jan 9, 2026 Calderaro Charles III Chief Technical Officer Sell 32.5 -3,727 -6.96% ✓ $269.2K
Jan 7, 2026 Jan 9, 2026 McCarthy Teresa Chief Human Resources Officer Sell 46.3 -1,965 -1.65% ✓ $141.9K
Jan 7, 2026 Jan 9, 2026 Moriarty John B Chief Legal Officer Sell 38.8 -2,374 -3.09% ✓ $171.5K
Jan 7, 2026 Jan 9, 2026 MacLean Michael F CFO Sell 42.5 -1,974 -3.00% ✓ $142.6K
Jan 7, 2026 Jan 9, 2026 Hughes Steven George Chief Medical Officer Sell 33.8 -2,373 -6.11% ✓ $171.4K
Jan 7, 2026 Jan 9, 2026 Flanagan W. Michael Chief Scientific Officer Sell 42.5 -2,373 -2.52% ✓ $171.4K
Dec 19, 2025 Dec 22, 2025 LEVIN ARTHUR A Director Neutral 37.5 -1,330 -0.77% ✗ -
Dec 17, 2025 Dec 19, 2025 Calderaro Charles III Chief Technical Officer Sell 97.5 +13,524 33.81% ✗ $699K
Dec 17, 2025 Dec 19, 2025 Flanagan W. Michael Chief Scientific Officer Sell 97.5 +13,805 17.21% ✗ $984.3K
Dec 17, 2025 Dec 19, 2025 Mosbrooker Eric Chief Commercial Officer Sell 100.0 +24,010 43.65% ✗ $3.4M
Dec 17, 2025 Dec 19, 2025 Boyce Sarah CEO Sell 37.5 -13,901 -4.54% ✗ $1.1M
Dec 17, 2025 Dec 19, 2025 Moriarty John B Chief Legal Officer Sell 100.0 +29,176 61.10% ✗ $1.9M
Dec 17, 2025 Dec 19, 2025 Gallagher Kathleen P. Chief Program Officer Sell 100.0 +30,634 61.02% ✗ $3M
Dec 17, 2025 Dec 19, 2025 McCarthy Teresa Chief Human Resources Officer Sell 100.0 +21,702 22.34% ✗ $1.2M
Oct 22, 2025 Oct 24, 2025 Hughes Steven George Chief Medical Officer Sell 32.5 -2,209 -5.38% ✓ $105K
Oct 15, 2025 Oct 17, 2025 McCarthy Teresa Chief Human Resources Officer Sell 15.0 -20,000 -17.08% ✓ $1M
Oct 3, 2025 Oct 7, 2025 Mosbrooker Eric Chief Commercial Officer Sell 22.5 -6,562 -10.66% ✓ $297.8K
Sep 22, 2025 Sep 23, 2025 Hughes Steven George Chief Medical Officer Sell 32.5 -2,208 -5.38% ✓ $89.6K
Sep 15, 2025 Sep 17, 2025 McCarthy Teresa Chief Human Resources Officer Sell 22.5 -15,000 -13.38% ✓ $621.1K
Sep 15, 2025 Sep 17, 2025 Hughes Steven George Chief Medical Officer Sell 37.5 -1,542 -3.82% ✓ $70K
Sep 11, 2025 Sep 12, 2025 Flanagan W. Michael Chief Scientific Officer Sell 17.5 -20,000 -19.96% ✓ $778.7K
Sep 5, 2025 Sep 9, 2025 WILSON TROY EDWARD Director Sell 5.0 -29,500 -30.21% ✓ $1.5M
Sep 5, 2025 Sep 5, 2025 Boyce Sarah CEO Sell 20.0 -50,000 -14.05% ✓ $2.5M
Sep 3, 2025 Sep 5, 2025 Mosbrooker Eric Chief Commercial Officer Sell 22.5 -6,563 -10.66% ✓ $308.9K
Sep 2, 2025 Sep 2, 2025 Gallagher Kathleen P. Chief Program Officer Sell 53.8 -188 -0.37% ✓ $8.9K
Aug 28, 2025 Aug 29, 2025 Boyce Sarah CEO Sell 23.8 -25,000 -7.56% ✓ $1.2M
Aug 22, 2025 Aug 22, 2025 Hughes Steven George Chief Medical Officer Sell 32.5 -2,208 -5.38% ✓ $102.5K
Aug 15, 2025 Aug 15, 2025 McCarthy Teresa Chief Human Resources Officer Sell 26.3 -10,000 -9.33% ✓ $465.6K
Aug 6, 2025 Aug 15, 2025 MacLean Michael F CFO Sell 5.0 -30,914 -31.96% ✓ $1.3M
Aug 13, 2025 Aug 15, 2025 Hughes Steven George Chief Medical Officer Sell 37.5 -1,542 -3.82% ✓ $71.9K
Aug 6, 2025 Aug 8, 2025 Mosbrooker Eric Chief Commercial Officer Sell 3.8 -130,807 -70.40% ✓ $5.8M
Aug 6, 2025 Aug 8, 2025 WILSON TROY EDWARD Director Sell 20.0 -95,054 -10.84% ✓ $4.3M
Aug 6, 2025 Aug 8, 2025 LEVIN ARTHUR A Director Sell 3.8 -107,500 -38.25% ✓ $5.1M
Aug 6, 2025 Aug 8, 2025 Hughes Steven George Chief Medical Officer Sell 15.0 -81,434 -19.78% ✓ $3.5M
Aug 4, 2025 Aug 5, 2025 Moriarty John B Chief Legal Officer Sell 37.5 -2,245 -4.49% ✓ $81.3K
Jun 17, 2025 Jun 18, 2025 Gallagher Kathleen P. Chief Program Officer Sell 48.8 -911 -1.78% ✓ $27.5K
Jun 10, 2025 Jun 12, 2025 Henig Noreen Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 10, 2025 Jun 12, 2025 BOESS CARSTEN Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 10, 2025 Jun 12, 2025 Kaye Edward M. MD Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 10, 2025 Jun 12, 2025 LEVIN ARTHUR A Director Neutral 82.5 +6,692 4.64% ✗ -
Jun 10, 2025 Jun 12, 2025 Skerjanec Simona Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 10, 2025 Jun 12, 2025 WILSON TROY EDWARD Director Neutral 90.0 +6,692 10.67% ✗ -
Jun 10, 2025 Jun 12, 2025 Thompson Tamar Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 10, 2025 Jun 12, 2025 Kim Jean Jinsun Director Neutral 90.0 +6,692 100.00% ✗ -
Jun 11, 2025 Jun 12, 2025 Flanagan W. Michael Chief Scientific Officer Sell 17.5 -20,000 -19.96% ✓ $657.7K
Jun 2, 2025 Jun 4, 2025 Gallagher Kathleen P. Chief Program Officer Sell 25.0 -5,875 -10.41% ✓ $190.8K
May 1, 2025 May 2, 2025 Gallagher Kathleen P. Chief Program Officer Sell 25.0 -5,875 -10.41% ✓ $190.3K
Apr 1, 2025 Apr 3, 2025 Gallagher Kathleen P. Chief Program Officer Sell 32.5 -5,875 -5.49% ✓ $163.5K
Mar 20, 2025 Mar 21, 2025 Hughes Steven George Chief Medical Officer Sell 22.5 -9,578 -11.62% ✓ $297.5K
Mar 20, 2025 Mar 21, 2025 Boyce Sarah CEO Sell 26.3 -31,540 -9.35% ✓ $979.6K
Mar 20, 2025 Mar 21, 2025 Flanagan W. Michael Chief Scientific Officer Sell 22.5 -11,780 -12.81% ✓ $365.9K
Mar 20, 2025 Mar 21, 2025 MacLean Michael F CFO Sell 28.8 -7,935 -7.58% ✓ $246.4K
Mar 20, 2025 Mar 21, 2025 McCarthy Teresa Chief Human Resources Officer Sell 32.5 -7,778 -7.41% ✓ $241.6K
Mar 11, 2025 Mar 12, 2025 Flanagan W. Michael Chief Scientific Officer Sell 17.5 -20,000 -17.86% ✓ $602.6K
Mar 3, 2025 Mar 4, 2025 Gallagher Kathleen P. Chief Program Officer Sell 25.0 -5,875 -10.41% ✓ $172.8K
Feb 3, 2025 Feb 5, 2025 Gallagher Kathleen P. Chief Program Officer Sell 25.0 -5,875 -10.41% ✓ $188.9K
Jan 21, 2025 Jan 23, 2025 LEVIN ARTHUR A Director Sell 45.0 -1,872 -1.28% ✓ $53.5K
Jan 21, 2025 Jan 23, 2025 MacLean Michael F CFO Sell 37.5 -3,287 -3.05% ✓ $94K
Jan 21, 2025 Jan 23, 2025 McCarthy Teresa Chief Human Resources Officer Sell 41.3 -2,959 -2.74% ✓ $84.6K
Jan 21, 2025 Jan 23, 2025 Flanagan W. Michael Chief Scientific Officer Sell 32.5 -5,672 -5.81% ✓ $162.2K
Jan 21, 2025 Jan 23, 2025 Boyce Sarah CEO Sell 38.8 -10,397 -2.99% ✓ $297.3K
Jan 21, 2025 Jan 23, 2025 Gallagher Kathleen P. Chief Program Officer Sell 17.5 -9,411 -15.69% ✓ $277.9K
Jan 21, 2025 Jan 23, 2025 Hughes Steven George Chief Medical Officer Sell 37.5 -3,947 -4.57% ✓ $112.9K
Jan 6, 2025 Jan 8, 2025 Flanagan W. Michael Chief Scientific Officer Neutral 90.0 +25,000 34.41% ✗ -
Jan 6, 2025 Jan 8, 2025 McCarthy Teresa Chief Human Resources Officer Neutral 90.0 +25,000 30.17% ✗ -
Jan 6, 2025 Jan 8, 2025 Moriarty John B Chief Legal Officer Neutral 90.0 +25,000 100.00% ✗ -
Jan 6, 2025 Jan 8, 2025 MacLean Michael F CFO Neutral 90.0 +25,000 30.14% ✗ -
Jan 6, 2025 Jan 8, 2025 Boyce Sarah CEO Neutral 90.0 +82,500 31.10% ✗ -
Jan 6, 2025 Jan 8, 2025 Hughes Steven George Chief Medical Officer Neutral 90.0 +25,000 40.73% ✗ -
Jan 6, 2025 Jan 8, 2025 Gallagher Kathleen P. Chief Program Officer Neutral 90.0 +25,000 71.50% ✗ -
Jan 6, 2025 Jan 8, 2025 Mosbrooker Eric Chief Commercial Officer Neutral 90.0 +25,000 69.21% ✗ -
Jan 6, 2025 Jan 8, 2025 Calderaro Charles III Chief Technical Officer Neutral 90.0 +40,000 100.00% ✗ -
Jan 8, 2025 Mosbrooker Eric Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 8, 2025 Gallagher Kathleen P. Chief Program Officer Neutral 52.5 - 0.00% ✗ -
Jan 8, 2025 Hughes Steven George Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 8, 2025 Calderaro Charles III Chief Technical Officer Neutral 52.5 - 0.00% ✗ -